Evnia ApS announces a new strategic partnership with Myo Health (www.myohealth.eu) to broaden our services in support of market access for medtech, biotech pharma and in-vitro diagnostics industries.
It is our common goal to drive regulatory, technical, clinical, reimbursement, pricing and market access consulting services focusing on generation, collection and analysis of real-world data and real-world evidence for the timely submission of HTA submissions!
Read more: https://lnkd.in/d–xpWKs
